Skip to main content
. 2017 Jun 1;7:2653. doi: 10.1038/s41598-017-02517-2

Figure 3.

Figure 3

Percentage of surviving mice following challenge with indicated amounts of ArtAB over time. BALB/c mice (n = 5–8) were challenged with graded doses of ArtABs (ArtAB-DT104, ArtAB-SW, or ArtAB-Sb) and observed daily over a 2-week period.